• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [21894 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2010     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Idursulfase (Elaprase) in the treatment of mucopolisacaridosis II
2008     Committee for New Health Technology Assessment (CNHTA) [IDUA gene, mutation[sequencing]]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idiopathic scoliosis: is video rasterstereography an adequate replacement for radiography in aftercare?]
2006     The Netherlands Organisation for Health Research and Development (ZonMw) [Identifying optimal diagnostic strategies algorithms with multiple tests. Ancillary study of Optimisation of diagnostic imaging use in patients with acute abdominal pain: cost-effectiveness analysis of imaging strategies (OPTIMA study)]
2012     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Identifying opportunities for health care disinvestment]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Identifying ineffective interventions and health technologies: models and their implementation]
2019     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Identification of psychosocial practices and interventions that support the adaptation and rehabilitation of adults with Prader-Willi Syndrome]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Identification of preventive health care for children and young people]
2021     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Identification of factors influencing the risk of absconding in a user with an intellectual disability, autism spectrum disorder or a mental health disorder]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idelalisib: benefit assessment according to §35a Social Code Book V]
2017     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idelalisib (chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idelalisib (chronic lymphocytic leukaemia) - Addendum to Commission A16-18]
2014     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idelalisib - Benefit assessment according to §35a Social Code Book V (dossier assessment)]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idecabtagene vicleucel (multiple myeloma) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idebenone: assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2012     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Idebenone for the treatment of Friedreich's ataxia]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idebenone (Leber hereditary optic neuropathy) - assessment according to §35a (para. 1., sentence 11) Social Code Book V (expiry of the decision)]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Icosapent ethyl (hypertriglyceridaemia) - Benefit assessment according to §35a Social Code Book V]
2022     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Icosapent ethyl (cardiovascular risk reduction) - Addendum to Commission A21-113]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (previously untreated chronic lymphocytic leukaemia) – Addendum to Commission A23-04]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (new therapeutic indication, Waldenstroem macroglobulinaemia) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (new therapeutic indication, chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (CLL) - Benefit assessment according to §35a Social Code Book V]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (chronic lymphocytic leukaemia): benefit assessment according to §35a Social Code Book V]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (chronic lymphocytic leukaemia): Addendum to Commission A16-39]
2023     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (chronic lymphocytic leukaemia, first line) - Benefit assessment according to §35a Social Code Book V]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib - Benefit assessment according to §35a Social Code Book V]
2015     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib - Assessment according to §35a (para. 1., sentence 10) Social Code Book V (dossier assessment)]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib - addendum to commission A16-04]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibalizumab (HIV infection) - Benefit assessment according to §35a Social Code Book V]
2011     Committee for New Health Technology Assessment (CNHTA) [I-125 permanent implant for prostate cancer]
2008     Finnish Office for Health Care Technology Assessment (Finohta) [Hysteroscopic sterilisation using a metal micro-insert]
2021     Norwegian Institute of Public Health (NIPH) [Hysterectomy for heavy menstrual bleeding: rapid health technology assessment]
2011     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Hypothermia therapy for treatment of neonatal hypoxic-ischemic encephalopathy]
2020     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Hypoglossal nerve stimulation systems for treatment of obstructive sleep apnea]
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hyperthermic intraperitoneal chemotherapy]
2013     Andalusian Health Technology Assessment Area (AETSA) [Hyperthermic intraperitoneal chemotherapy. Efficacy and safety in the treatment of ovarian cancer peritoneal carcino matosis]
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hyperthermia]
2020     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Hyperbaric oxygenotherapy for fybromialga, peripheral vascular disease, neurological disease and other indications]
2012     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hyperbaric oxygen treatment of injuries after radiotherapy for head and neck cancer - a health technology assessment]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hyperbaric oxygen therapy: Evidence report for the S3 guideline on atraumatic femoral head necrosis in adults]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hyperbaric oxygen therapy vs. core decompression: Evidence report for the S3 guideline on atraumatic femoral head necrosis in adults]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyperbaric oxygen therapy in pseudoarthrosis]
2012     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyperbaric oxygen therapy in lateral sinus thrombosis]
2020     Norwegian Institute of Public Health (NIPH) [Hyperbaric oxygen therapy for radiation-induced cystitis]
2008     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hyperbaric oxygen therapy for idiopathic osteonecrosis of the femoral head in adults]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hyperbaric oxygen therapy for diabetic foot syndrome]
2017     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyperbaric oxygen therapy for chronic ulcers]
2007     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hyperbaric oxygen therapy for burns]
2009     Committee for New Health Technology Assessment (CNHTA) [Hyoid myotomy suspension]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Hydrotherapy in skeletal muscle disorders]
2018     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Hydrocortisone (adrenal insufficiency) - Benefit assessment according to §35a Social Code Book V]
2013     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Hybrid operating room]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Hyaluronic acid dermal fillers in skin repair procedures]
2009     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors]
2020     Institute for Clinical Effectiveness and Health Policy (IECS) [Human papilloma virus (HPV) vaccine in patients with HPV lesions or infection]
2000     Basque Office for Health Technology Assessment (OSTEBA) [Human assisted reproductive techniques: Description of the available therapeutic options]
2000     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [HTA, health services research, and clinical practice. Report from a symposium in evidence based health care]
2008     Norwegian Knowledge Centre for the Health Services (NOKC) [HPV RNA test for cervical cancer]
2008     Committee for New Health Technology Assessment (CNHTA) [HPV genotype(PCR-RFMP)]
2014     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [How to improve the management of depression? A qualitative approach]
2019     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [How do non-drug interventions influence coping with suicidal crises in unipolar depression?]
2009     The Swedish Council on Health Technology Assessment (SBU) [How can drug consumption among the elderly be improved?]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hospice without walls]
2007     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Hormones for therapy of climacteric afflictions]
2018     Institute for Clinical Effectiveness and Health Policy (IECS) [Hormone receptor testing in breast cancer]
2005     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Home-based rehabilitation of patients suffering from stroke]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home-based oral nutritional supplements in cancer patients with moderate-severe malnutrition undergoing active treatment]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home-based oral nutritional supplements in cancer patients who require modification of the usual ordinary diet due to mucositis]
2009     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Home visits to patients with severe COPD - a health technology assessment]
2017     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Home use of a mechanical cough-assist insufflation-exsufflation device for adults with neuromuscular diseases who do not require ventilatory support]
2007     Basque Office for Health Technology Assessment (OSTEBA) [Home health care of patients with terminal illnesses in the Basque Autonomous Community]
2022     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Home enteral nutrition in older patients with severe protein-energy malnutrition after hip fracture]
2011     Institut national d'excellence en sante et en services sociaux (INESSS) [Home diagnosis of obstructive sleep apnea in children]
2010     The Swedish Council on Health Technology Assessment (SBU) [Home blood pressure monitoring]
2023     Institute for Clinical Effectiveness and Health Policy (IECS) [Holmium laser in non-prostate endourologic conditions]
2009     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Holmium laser enucleation of benign prostatic hyperplasia]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Holmium laser enucleation in benign prostatic hyperplasia]
2008     Committee for New Health Technology Assessment (CNHTA) [HLA-B51, genotyping[allele-specific PCR]]
2008     Committee for New Health Technology Assessment (CNHTA) [HLA-B51 nested PCR]
2010     Committee for New Health Technology Assessment (CNHTA) [HLA antibody identification, single antigen class i, class ii (luminex)]
2012     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [HIV screening in the general population]
2009     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [HIV infection detection quick test]
2008     Committee for New Health Technology Assessment (CNHTA) [HIV antibody test (including oral fluid)]
1999     Basque Office for Health Technology Assessment (OSTEBA) [Hip replacement: indications of appropriate use]
2000     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Hip replacement with osteoarthritis]
2010     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Hip protectors in long-term care]
2014     Haute Autorite de sante (HAS) [Hip implants]
2019     Institute for Clinical Effectiveness and Health Policy (IECS) [Hip arthroscopy for painful hip treatment]
2009     Committee for New Health Technology Assessment (CNHTA) [HINT (Hearing in Noise Test)]
2023     The Danish Health Technology Council (DHTC) [High-tech hospital beds for use in intensive and neurological wards]
2010     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [High-intensity focussed ultrasound (HIFU) for the treatment of prostate cancer]
2008     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [High-intensity focused ultrasound for prostate cancer]
2021     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [High-flow therapy for self-use in advanced COPD or chronic type 1 respiratory failure]
2014     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [High-dose rate brachytherapy in the treatment of mobile tongue cancer]
2012     Andalusian Health Technology Assessment Area (AETSA) [High-dose chemotherapy in the salvage treatment of metastatic germ cell tumours]
2009     The Netherlands Organisation for Health Research and Development (ZonMw) [High throughput and comprehensive resequencing of cardiomyopathy genes by CHIP based DNA-sequencing technology (CardioCHIP)]
2008     Committee for New Health Technology Assessment (CNHTA) [High intensity focused ultrasound]
2021     Andalusian Health Technology Assessment Area (AETSA) [High intensity focused ultrasound (HIFU) in organ-confined prostate tumors]